ADCT · ADC Therapeutics S.A.

Summary

ADC Therapeutics S.A. filed an 8-K on March 10, 2026, under Item 2.02 with Exhibit 99.1 Press Release, indicating results of operations or earnings information. Exhibit 99.1 is not deemed 'filed' for purposes of Section 18 of the Exchange Act.

Key takeaways

• Form 8-K filed on 2026-03-10
• Item 2.02 Results of Operations
• Exhibit 99.1 Press Release dated March 10, 2026
• Exhibit 99.1 not deemed 'filed' under Section 18
• Exhibit 104 Cover Page Interactive Data File